职位描述

  Responsibilities

 • Critically review data from contract partners, provide timely feedback to secure
prompt resolution of technical and quality findings. • Work effectively in cross-functional teams and support the team objectives in
delivering project milestones.
• Work closely with CMOs and CROs to ensure timely release of manufactured
drug substances and drug products.
• Draft or review pharmaceutical development reports, relevant sections of CMC
documentations in support of INDs, IMPDs and NDAs submissions.
• Responsible to use science driven and QbD and risk management-based
approach to develop robust API and drug product manufacturing processes.
• Responsible for API manufacturing and drug product manufacturing process
development, scale-up and the manufacturing to enable project advancement
from preclinical to clinical and from clinical to commercialization.
• Critically review data from contract partners, provide timely feedback to secure
prompt resolution of technical and quality findings.
• Work effectively in cross-functional teams and support the team objectives in
delivering project milestones.
• Work closely with CMOs and CROs to ensure timely release of manufactured
APIs and drug products.
• Author and review pharmaceutical development reports, relevant sections of
CMC documentations in support of INDs, IMPDs and NDAs submissions.   

• Establish SOPs and workflows and find creative ways to resolve problems.
• Compiles and reports pharmaceutical development status to study teams and
senior management.
• Assists in designing and continuously improving Quality Control systems,
processes and procedures.
• Assists with developing and validating testing methodology.

其他要求

招聘人数: 3
汇报对象: Senior Director of Pharmaceutical Development
职能类别: 药物分析/药品检验

公司介绍

诗迈医药是医药产业生态数智化赋能平台,集专利转化、海归创业孵化、投资融资、产业规划、产业园开发、产业园运营、专业医药猎头、精准招商、培训咨询、注册认证、商务资源等产业生态服务于一体,是国家高新与专精特新企业,服务业领军企业,最大的专业医药猎头公司,深耕医药产业16年。公司与112个政府医药产业园、名企、医药高校、大三甲医院、医药投资机构、证券公司等建立了战略联盟,投资建设孵化平台3万方,开发产业园50万方,实验室装修60余次,主导政府产业规划与政策制订67项,主编《中国医药人才发展白皮书》、《中国创新药人力资源管理》,公司在海内外设有21家分子公司,欧美日设有合作中心,公司构建了全国最大的生命健康产业人才大数据平台(586万人)及产业链上下游资源平台(10.21万家)。孵化目标人才:领先技术海归科学家和业绩丰富上下游企业高管。投资孵化方向:合成生物学与生物制造、消费医疗与大健康、医疗器械与耗材、数字健康与装备、上下游试剂与设备、创新药等。

企业信息

  • 名称:某南京公司
  • 行业:制药.生物
  • 性质: 中外合营(合资/合作)
  • 规模: 100-499人

相关职位 更多

    求职技巧 更多